Published in JAMA on January 05, 1994
Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev (2005) 6.02
Seizure Risk with Vaccination. Epilepsy Curr (2002) 0.75
Above all, do no harm: assessing the risk of an adverse reaction. West J Med (2001) 0.75
Vaccination Triggers, Rather Than Causes, Seizures. Epilepsy Curr (2015) 0.75
Pertussis vaccines. A progress report. JAMA (1994) 0.75
The distribution over time of costs and social net benefits for pertussis immunization programs. Int J Health Care Finance Econ (2009) 0.75
The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med (1998) 6.75
A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. N Engl J Med (1996) 4.86
A randomized trial of a consultation service to reduce falls in nursing homes. JAMA (1997) 4.55
Characterization of non-beta-lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrob Agents Chemother (1984) 4.25
Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry (2001) 4.04
Morbidity and mortality associated with the July 1980 heat wave in St Louis and Kansas City, Mo. JAMA (1982) 3.69
Influenzavirus infections in Seattle families, 1975-1979. I. Study design, methods and the occurrence of infections by time and age. Am J Epidemiol (1982) 3.55
Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA (1999) 3.53
Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr (2000) 3.53
Influenzavirus infections in Seattle families, 1975-1979. II. Pattern of infection in invaded households and relation of age and prior antibody to occurrence of infection and related illness. Am J Epidemiol (1982) 3.37
Long-term epidemiology of infections with Mycoplasma pneumoniae. J Infect Dis (1979) 3.12
Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J Infect Dis (1996) 2.96
Correlation of circulating capsular polysaccharide with bacteremia in pneumococcal pneumonia. Infect Immun (1972) 2.93
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J Infect Dis (2000) 2.90
Risk factors for delayed immunization in a random sample of 1163 children from Oregon and Washington. Pediatrics (1993) 2.74
Mycoplasma pneumoniae pneumonia in an urban area. Five years of surveillance. JAMA (1970) 2.58
Epidemiology of Mycoplasma pneumoniae infection in families. JAMA (1966) 2.49
Failure to detect ampicillin-resistant, non-beta-lactamase-producing Haemophilus influenzae by standard disk susceptibility testing. Antimicrob Agents Chemother (1986) 2.38
Increased frequency of serum antibodies to Chlamydia trachomatis in infertility due to distal tubal disease. Lancet (1982) 2.38
Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984. JAMA (1987) 2.28
Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. Pediatrics (1997) 2.25
Laboratory diagnosis of pertussis: the state of the art. Pediatr Infect Dis J (1987) 2.13
Mycoplasma pneumoniae infections in patients with immunodeficiency syndromes: report of four cases. J Infect Dis (1973) 2.11
Continuing measles transmission in students despite school-based outbreak control program. Am J Epidemiol (1985) 2.09
The Vaccine Adverse Event Reporting System (VAERS). Vaccine (1994) 2.02
Characterization of Haemophilus influenzae type b fimbriae. Infect Immun (1984) 2.00
The health and economic burden of cigarette smoking in Georgia in 1985. J Med Assoc Ga (1989) 1.94
Changing epidemiology of dengue hemorrhagic fever in Thailand. Epidemiol Infect (1999) 1.94
Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum. Am Rev Respir Dis (1985) 1.85
A permeability barrier as a mechanism of chloramphenicol resistance in Haemophilus influenzae. Antimicrob Agents Chemother (1985) 1.84
Bacteriology of acute otitis media: a new perspective. J Pediatr (1992) 1.80
Health impact of measles vaccination in the United States. Pediatrics (1985) 1.71
Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children. Pediatrics (2001) 1.70
Sexually transmitted diseases and tubal pregnancy. Sex Transm Dis (1991) 1.69
Practical experiences in obtaining informed consent for a vaccine trial in rural Africa. N Engl J Med (1997) 1.67
Detection of relatively penicillin G-resistant Neisseria meningitidis by disk susceptibility testing. Antimicrob Agents Chemother (1987) 1.67
Diagnosis of Mycoplasma pneumoniae pneumonia: sensitivities and specificities of serology with lipid antigen and isolation of the organism on soy peptone medium for identification of infections. J Clin Microbiol (1990) 1.63
Efficacy of whole-cell pertussis vaccine in preschool children in the United States. JAMA (1992) 1.60
Pneumococcal isolations from patients with pneumonia and control subjects in a prepaid medical care group. Am Rev Respir Dis (1975) 1.60
HIV-1 subtypes and male-to-female transmission in Thailand. Lancet (1995) 1.59
Epidemiological features of pertussis in the United States, 1980-1989. Clin Infect Dis (1992) 1.55
Viral and mycoplasmal pneumonia in a prepaid medical care group during an eight-year period. Am J Epidemiol (1973) 1.55
An explosive point-source measles outbreak in a highly vaccinated population. Modes of transmission and risk factors for disease. Am J Epidemiol (1989) 1.53
Ampicillin resistance and penicillin-binding proteins of Haemophilus influenzae. J Gen Microbiol (1986) 1.52
Pneumonia due to Mycoplasma pneumoniae. Its incidence in the membership of a co-operative medical group. N Engl J Med (1966) 1.52
Isolation of cytomegalovirus from a cohort of 100 infants throughout the first year of life. Proc Soc Exp Biol Med (1969) 1.50
Respiratory rate and signs in roentgenographically confirmed pneumonia among children in China. Pediatr Infect Dis J (1995) 1.50
The principal protein antigens of isolates of Mycoplasma pneumoniae as measured by levels of immunoglobulin G in human serum are stable in strains collected over a 10-year period. Infect Immun (1987) 1.48
Longitudinal studies of types A and B influenza among Seattle schoolchildren and families, 1968-74. J Infect Dis (1976) 1.47
Adenovirus type 3 epidemic associated with intermittent chlorination of a swimming pool. Arch Environ Health (1968) 1.41
Electrodiagnosis reliability in the diagnosis of infant botulism. J Pediatr (1992) 1.41
Practical steps to smoking cessation for recovering alcoholics. Am Fam Physician (1998) 1.40
A Hong Kong influenza immunity three years after immunization. JAMA (1973) 1.40
Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979. J Infect Dis (1992) 1.39
Statistical comparison of ligand-binding kinetics. Stat Med (1989) 1.39
Can a one-day workshop alter surgeons' teaching practices? Am J Surg (1998) 1.38
Outbreak of paralytic poliomyelitis in Albania, 1996: high attack rate among adults and apparent interruption of transmission following nationwide mass vaccination. Clin Infect Dis (1998) 1.38
Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control. Vaccine (2000) 1.38
A comparison of laboratory and clinical methods for diagnosing pertussis in an outbreak in a facility for the developmentally disabled. J Infect Dis (1988) 1.37
Plasmid-mediated resistance in multiply resistant Haemophilus influenzae type b causing meningitis: molecular characterization of one strain and review of the literature. J Infect Dis (1984) 1.32
Rates of pneumonia during influenza epidemics in Seattle, 1964 to 1975. JAMA (1979) 1.31
Influenza B in households: virus shedding without symptoms or antibody response. Am J Epidemiol (1987) 1.29
Isolation of TRIC agents and mycoplasma from the genito-urinary tracts of patients of a venereal disease clinic. Am J Ophthalmol (1967) 1.28
Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis. J Pediatr (1998) 1.27
Isolation of Mycoplasma hominis, T-strains, and cytomegalovirus from the cervix of pregnant women. Am J Obstet Gynecol (1970) 1.26
Implementing recommendations for the early detection of breast and cervical cancer among low-income women. MMWR Recomm Rep (2000) 1.25
Pertussis epidemic in Oklahoma. Difficulties in preventing transmission. Am J Dis Child (1986) 1.23
A comparison of multiple regimens of pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine and pneumococcal polysaccharide vaccine in toddlers. Vaccine (2000) 1.20
Septic arthritis versus transient synovitis of the hip: the value of screening laboratory tests. Ann Emerg Med (1992) 1.20
Rhinoviruses in Seattle families, 1975-1979. Am J Epidemiol (1985) 1.19
Mycoplasma pneumoniae in the community. Am J Epidemiol (1971) 1.17
Benzodiazepines and the risk of falls in nursing home residents. J Am Geriatr Soc (2000) 1.17
Single-dose monovalent A 2 -Hong Kong influenza vaccine. Efficacy 14 months after immunization. JAMA (1971) 1.16
Influenza surveillance by age and target group. Am J Epidemiol (1979) 1.14
Legionnaires' disease in a prepaid medical-care group in Seattle 1963--75. Lancet (1979) 1.13
Urging the alcoholic client to quit smoking cigarettes. Addict Behav (1983) 1.12
Genotypic stability of cold-adapted influenza virus vaccine in an efficacy clinical trial. J Clin Microbiol (2000) 1.10
Enhancing student practicum opportunities: the outbreak investigation option. J Public Health Manag Pract (1995) 1.10
Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants. J Pediatr (1996) 1.08
Epidemiology and control of dengue virus infections in Thai villages in 1987. Am J Trop Med Hyg (1989) 1.08
Diagnostic usefulness of mycobacterial skin test antigens in childhood lymphadenitis. Pediatr Infect Dis J (1989) 1.08
Isolation of respiratory syncytial and influenza viruses from the sputum of patients hospitalized with pneumonia. J Infect Dis (1983) 1.07
Comparative study between tramadol and dexamethasone as an admixture to bupivacaine in supraclavicular brachial plexus block. JNMA J Nepal Med Assoc (2008) 1.06
Acquisition of mycoplasmata and T-strains during infancy. J Infect Dis (1970) 1.06
Human serologic response to envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis. J Infect Dis (1991) 1.04
Antibody responses to bovine parainfluenza virus type 3 (PIV3) vaccination and human PIV3 infection in young infants. J Infect Dis (2001) 1.04
Measles seroconfirmation using dried capillary blood specimens in filter paper. Pediatr Infect Dis (1984) 1.03
Incidence and etiology of pneumonia, croup and bronchiolitis in preschool children belonging to a prepaid medical care group over a four-year period. Am J Epidemiol (1973) 1.03
Radiographic study of mycoplasma pneumoniae pneumonia. Am Rev Respir Dis (1973) 1.02
Epidemiological studies of Mycoplasma pneumoniae infections in civilians. Ann N Y Acad Sci (1967) 1.02
Second attacks of pneumonia due to Mycoplasma pneumoniae. J Infect Dis (1977) 1.02
Mycoplasma pneumoniae infection followed by Haemophilus influenzae pneumonia and bacteremia. Am Rev Respir Dis (1975) 1.01
Cloning and expression in Escherichia coli of a gene encoding nonenzymatic chloramphenicol resistance from Pseudomonas aeruginosa. Antimicrob Agents Chemother (1986) 1.01
Use of bacterial antigen detection in the diagnosis of pediatric lower respiratory tract infections. Pediatrics (1986) 0.98
Comparison of ophthalmic silver nitrate solution and erythromycin ointment for prevention of natally acquired Chlamydia trachomatis. Sex Transm Dis (1988) 0.97
Persistence of protection through 33 months of age provided by immunization in infancy with two three-component acellular pertussis vaccines. Stage II Working Group. Vaccine (1998) 0.97
Epidemic of fever of unknown origin in rural Thailand, caused by influenza A (H1N1) and dengue fever. Southeast Asian J Trop Med Public Health (1990) 0.97
Patterns and determinants of use of antibiotics for acute respiratory tract infection in children in China. Pediatr Infect Dis J (1997) 0.97
Evaluation of the MycoDot test for the diagnosis of tuberculosis in HIV seropositive and seronegative patients. Int J Tuberc Lung Dis (1997) 0.97